Showing results (201-210 of 251) with videos related to

Sort By:
Pageof 26
Advances in Biological Regulation|October 26, 2016
Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasisJames A McCubrey, Kvin Lertpiriyapong, Timothy L Fitzgerald, et al.
Advances in Biological Regulation|October 6, 2020
Therapeutic resistance in breast cancer cells can result from deregulated EGFR signalingLinda S Steelman, William H Chappell, Shaw M Akula, et al.
Veterinary Ophthalmology|June 23, 2015
Sudden acquired retinal degeneration syndrome (SARDS) - a review and proposed strategies toward a better understanding of pathogenesis, early diagnosis, and therapyAndrás M Komáromy, Kenneth L Abrams, John R Heckenlively, et al.
Cell Cycle (Georgetown, Tex.)|May 4, 2010
The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapyStephen L Abrams, Linda S Steelman, John G Shelton, et al.
Leukemia|March 14, 2008
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapyJ A McCubrey, L S Steelman, S L Abrams, et al.
Cells|May 6, 2020
Targeting GSK3 and Associated Signaling Pathways Involved in CancerPrzemysław Duda, Shaw M Akula, Stephen L Abrams, et al.
Oncotarget|July 7, 2011
Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapyMelissa L Sokolosky, Kristin M Stadelman, William H Chappell, et al.
Leukemia|August 8, 2008
Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistanceJ A McCubrey, S L Abrams, G Ligresti, et al.
Advances in Biological Regulation|December 6, 2021
Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53Stephen L Abrams, Shaw M Akula, Linda S Steelman, et al.
Leukemia|March 14, 2008
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemiaL S Steelman, S L Abrams, J Whelan, et al.
Pageof 26